Canopy Growth Corp is still a big question mark, this investor says

Dec 14 19:12 2019 Print This Article

With Canada’s pot companies still licking their wounds after a sector-wide meltdown, it’s unclear where investors can find real value among the ruins. And while many see Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart, News TSX:WEED) as a sure bet to rise from the ashes, according to Christine Poole of GloveInvest Capital, it […]

The post Canopy Growth Corp is still a big question mark, this investor says appeared first on Cantech Letter.

Read More

About Article Author

Cantech Letter

Founded in 2008 by Nick Waddell, Cantech Letter is an online magazine focusing on Canadian technology. The site has grown into one of the most popular and respected financial sites in Canada, and was described by Canadian Business Magazine as “one of Canada’s premier technology newsletters”. Waddell, who is Senior Editor, is routinely called on by the mainstream media for perspective on Canadian technology, and has been featured on BNN, CTV News Channel, and the CBC program “The Lang and O’Leary Exchange” in addition to mainstream print media such as The Guardian, The International Business Times, The Globe and Mail, Macleans, The Waterloo Record , Canadian Business, Slate, and Business Insider. You can email Nick at nick@cantechletter.com Cantech Letter is focused on those companies listed on the TSX and TSXV Technology, Cleantech and Life Sciences Sectors. Each year we present the Cantech Letter Awards, which honor Canada’s Top Technology Stock and Top Technology Stock Executive.

Related Items

The Seemingly Unstoppable US Stock Market?

Jeff Cox of CNBC reports the stock market just set another record, this one going back to 1972:The seemingly unstoppable U.S. stock market continues to set new records, with the latest standard a trend that hasn’t been beaten since 1972.One gauge closely watched by traders is where the market is ...

Value Creation in Direct Private Equity

Before the holidays, Institutional Investor published a good interview with BlackRock’s Colm Lanigan, Co-Founder, Managing Director and Senior Investor, Long Term Private Capital, discussing value creation in direct private equity:When investors look at public markets today, many see high curren ...

MedMen is a stock to avoid, this fund manager says

US cannabis retailer MedMen Enterprises (MedMen Enterprises Stock Quote, Chart, News CSE:MMEN) should be a no-go zone for investors, at least until it shows signs of righting the ship. That’s the advice from James Telfser of Aventine Asset Management who peeled back the cover on MedMen and didn ...

Moving Beyond Compliance as a Privacy Policy Motivator

Over the next 18 months, Canadian businesses can expect to see changes in Canada’s privacy laws. In particular, the Office of the Privacy Commissioner of Canada will likely be granted more enforcement powers. The government sees compliance enforcement as incentive to business to build trust in the ...

HLS Therapeutics has upside left, says Stifel GMP

HLS Therapeutics (HLS Therapeutics Stock Quote, Chart, News TSX:HLS) received a target raise from Stifel GMP analyst Justin Keywood on Thursday as a result of Heath Canada’s acceptance of a New Drug Submission for HLS’ in-licensed schizophrenia drug PERSERIS. The analyst said the drug could rea ...

Air Canada is still an undervalued stock, this investor says

After hitting a new all-time high, Air Canada (Air Canada Stock Quote, Chart, News TSX:AC) has been flying low over the past couple of weeks. Is the dip a good buying opportunity? You bet, says James Telfser of Aventine Asset Management. Shares of Air Canada were down this week along with the rest ...

Washington Bill Looks to Ban Marijuana Concentrates

There is no doubt about it, lawmakers are always trying to find new ways to spoil the fun we’re all supposed to be having out here in the big, bad world. And Washington state is certainly no exception. Some of the suits in Olympia are now so convinced that high-powered marijuana is contributing t ...

Columbia Care has a 131 per cent upside, says PI Financial

US multi-state operator Columbia Care (Columbia Care Stock Quote, Chart, News NEO:CCHW) received a coverage initiation from PI Financial on Wednesday, where analyst Jason Zandberg started the stock off with a “Buy” rating and C$11.00 price target, saying that best-in-class management plus expos ...

Which cannabis ETF is the best?

Wondering which cannabis ETF is the best? Choose Evolve Marijuana ETF (Evolve Marijuana Quote, Chart, News TSX:SEED) over Horizons HMMJ (Horizons HMMJ Quote, Chart, News TSX:HMMJ), this advisor says Wondering how to play the marijuana sector? Try an ETF, says National Bank Financial’s Daniel Stra ...

Canopy Growth will remain a problem for Constellation Brands, this investor says

The write-downs likely aren’t done yet. That’s the takeaway from portfolio manager Jason Mann’s assessment of Constellation Brands (Constellation Brands Stock Quote, Chart, News NYSE:STZ) and its troubled investment in cannabis company Canopy Growth (Canopy Growth Stock Quote, Chart, News TSX ...

The worst is over for Organigram, says Raymond James

Operational excellence was the takeaway from Organigram Holdings (Organigram Holdings Stock Quote, Chart, News TSX:OGI) in its latest quarter, according to Raymond James analyst Rahul Sarugaser, who in an update to clients on Wednesday raised his rating for OGI from “Market Perform 3” to “Out ...

PI Financial cuts price target on Aphria

Following the company’s second quarter results, PI Financial analyst Jason Zandberg has cut his price target on Aphria (Aphria Stock Quote, Chart, News TSX:APHA), though the analyst has maintained his “Buy” rating on the stock. On Tuesday, Aphria reported its Q2, 2020 results. The company los ...